SS

Sumeet Suresh Girme

Director Director DIN 06499006
DIN 06499006 First appointment Feb 2013 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Feb 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Sumeet Suresh Girme

Data last updated:

Sumeet Suresh Girme has 13 years in corporate governance. Formerly with 1 company, such as Rich Pharma India Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 06499006
Primary Designation Director
First Appointment 15 Feb 2013
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rich Pharma India Private Limited U24239PN2008PTC131753
Director15 Feb 20132008₹5.10 Cr (FY 2016)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rich Pharma India Private Limited
Premium access

Shareholding and investment profile for Sumeet Suresh Girme

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sumeet Suresh Girme

Sumeet Suresh Girme has 13 years in corporate governance. Formerly with 1 company, such as Rich Pharma India Private Limited. Engaged in General Business. Contributes to corporate operations.

Sumeet Suresh Girme has expertise in General Business.

Sumeet Suresh Girme has 13 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available